Hot Investor Mandate 1: Large Taiwan VC Seeking Global Investment Opportunities in All Life Sciences Sectors

25 Jan

A venture capital firm with headquarters in Taiwan also has additional venture partners based in USA and multiple Asian countries. Based on National Development Fund in Taiwan, Taiwan Government matched 30% of the fund formed between local and international investors. The firm has over $100M AUM and its initial size of investment is in $1-6M range. However, the firm has the capacity to invest more in companies they identify as a strong fit. The firm is looking for companies globally but would prefer companies that have a Taiwan angle.

The firm is an opportunistic investor that currently considering Therapeutics, Medical Devices, Diagnostics, Biotechnology R&D, and Healthcare IT companies. The firm is open to many sectors in therapeutics but would prefer phases that past pre-clinical. The firm is open to medical devices with all FDA regulatory pathways, including 510k, PMA, and software-enabled device. The firm invest in any phases in medical devices and diagnostics especially in clinical. The firm looks into any indications except orphan disease.

The firm currently will invest in privately held companies only. The firm has no specific requirements for management team. The firm can participate as either lead or co-investor and generally requests a board seat or board observer rights in its portfolio company.

If you are interested in more information about this investor and other investors tracked by LSN, please email mandates@lifesciencenation.com.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: